Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: a single-center retrospective study

Table 2 Secondary outcomes regarding time intervals measured in the operating room and PACU

Variables	Group S (n = 68)	Group P (n = 67)	P-value
Reversal agent injection interval 1^a (min)	4.9 ± 3.2	6.8 ± 4.8	0.026
Reversal agent injection interval 2^b (min)	22.3 ± 8.3	25.7 ± 10.4	0.084
Recovery time in PACU^c (min)	3.1 ± 5.3*	8.1 ± 9.0	≤0.001
Time to reach Ramsay sedation score 2 in PACU (min)	3.1 ± 5.3*	8.1 ± 9.0	≤0.001

The patient data are presented as mean ± SD. Group S: patients who received sugammadex as a reversal agent. Group P: patients who received pyridostigmine as a reversal agent
PACU post-anaesthesia care unit
*P < 0.025 vs. group P (Bonferroni correction)
^athe interval between the end of surgery and the administration of reversal agents
^bthe interval between the administration of the last dose of rocuronium and the administration of reversal agents
^cthe time to reach modified Aldrete score 10

ISSN: 1471-2253